MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orzechowski, H.-D.
Right arrow Articles by Paul, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orzechowski, H.-D.
Right arrow Articles by Paul, M.

Vol. 60, Issue 6, 1332-1342, December 2001

Transcriptional Mechanism of Protein Kinase C-Induced Isoform-Specific Expression of the Gene for Endothelin-Converting Enzyme-1in Human Endothelial Cells

Hans-Dieter Orzechowski, Astrid Günther,1 Stefan Menzel,2 Andreas Zimmermann, Heiko Funke-Kaiser, Robert Real,3 Thomas Subkowski, Frank S. Zollmann, and Martin Paul

Institute of Clinical Pharmacology and Toxicology, Benjamin Franklin Medical Center, Freie Universität, Berlin, (H.-D.O., A.G., S.M., A.Z., H.F.-K., R.R., F.S.Z., M.P.), and Main Laboratory, BASF AG, Ludwigshafen, Germany (T.S.)

Isoform-specific expression of endothelin-converting enzyme (ECE)-1, the major big endothelin-processing enzyme, is controlled by alternative promoters. Signaling pathways and transcriptional mechanisms of ECE-1 mRNA expression are largely unknown. To investigate ECE-1 isoform expression after protein kinase C (PKC) activation, we used phorbol 12-myristate 13-acetate (PMA) to stimulate primary cultured human umbilical vein endothelial cells and the related EA.hy926 cell line. ECE-1a mRNA was up-regulated (approximately 3-fold), whereas mRNA of alternative isoforms (b, c, and d) was unchanged, which was confirmed on the protein level. PMA effects on mRNA expression were suppressed by the PKC inhibitors H-7 and Calphostin C. Because increased ECE-1a expression was preceded by induction of the transcription factor Ets-1, we performed gel shift assays and demonstrated specific DNA/protein interactions involving the ETS binding motif GGAA. Luciferase reporter assays showed that PMA induced ECE-1a promoter activity about 2.5-fold in EA.hy926 cells. Similarly, coexpression of Ets-1 protein resulted in a dose-dependent increase in ECE-1a promoter activity (more than 8-fold). Using gel shift assays and mutation analysis, we identified two tandemly arranged Ets-1 binding sites (EBS) at -638 and -658, respectively, that are involved in transcriptional activation of the ECE-1a promoter by PMA or Ets-1. Moreover, we also found evidence for binding of a transcriptional repressor to EBS -638. The inhibitor of mitogen-activated protein kinase kinase, PD98059, inhibited PMA effects on ECE-1a mRNA expression and promoter activity, respectively. Our results provide the first detailed analysis of signaling pathways and transcriptional mechanisms involved in isoform-specific ECE-1 gene expression.


1 Present address: Department of Neurology, Benjamin Franklin Medical Center Freie Universität, Berlin, Germany.

2 Present address: Cytonet GmbH & Co. KG, Weinheim, Germany.

3 Present address: Department of Urology, Benjamin Franklin Medical Center Freie Universität, Berlin, Germany.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Khamaisi, R. Dahan, S. Hamed, Z. Abassi, S. N. Heyman, and I. Raz
Role of Protein Kinase C in the Expression of Endothelin Converting Enzyme-1
Endocrinology, March 1, 2009; 150(3): 1440 - 1449.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
W. R. Kaufman and J. L. Minion
Pharmacological characterization of the ergot alkaloid receptor in the salivary gland of the ixodid tick Amblyomma hebraeum
J. Exp. Biol., July 1, 2006; 209(13): 2525 - 2534.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
L. Fisk, N. N. Nalivaeva, and A. J. Turner
Regulation of endothelin-converting enzyme-1 expression in human neuroblastoma cells.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1048 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D.-S. Choi, D. Wang, G.-Q. Yu, G. Zhu, V. N. Kharazia, J. P. Paredes, W. S. Chang, J. K. Deitchman, L. Mucke, and R. O. Messing
From the Cover: PKC{varepsilon} increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice
PNAS, May 23, 2006; 103(21): 8215 - 8220.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Muller, A. Barret, E. Etienne, R. Meidan, O. Valdenaire, P. Corvol, and C. Tougard
Heterodimerization of Endothelin-converting Enzyme-1 Isoforms Regulates the Subcellular Distribution of This Metalloprotease
J. Biol. Chem., January 3, 2003; 278(1): 545 - 555.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. J. MacLeod, R. D. Husain, D. A. Gage, and K. Ahn
Constitutive Phosphorylation of Human Endothelin-converting Enzyme-1 Isoforms
J. Biol. Chem., November 22, 2002; 277(48): 46355 - 46363.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics